Mandelia Ashish

Average Profitability
<0.0001%
Insider Buys Quantity
1
Insider Buys Sum
$92,558.88
Insider Sells Quantity
9
Insider Sells Sum
$269,899.75

Insider Activity of Mandelia Ashish

According to the SEC Form 4 filings, Mandelia Ashish, being in a position of

  1. VP, Chief Accounting Officer at Mersana Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 13241 share for $29,915,
    over all time since 2020-06-30, has bought 6766 shares for $92,559, and sold 31014 shares for $269,900.

The largest purchase of all time was on 2020-06-30 and amounted to 6766 shares of Mersana Therapeutics, Inc. for $92,559.

The largest sale of all time was on 2020-07-02 and amounted to 6766 shares of Mersana Therapeutics, Inc. for $152,167.

Biography of Mandelia Ashish

No biography is available at this moment.

2024-10-03SaleMersana Therapeutics, Inc.
MRSN
VP, Chief Accounting Officer
3,361
0.0029%
$1.96$6,588+3.96%
2024-10-02SaleMersana Therapeutics, Inc.
MRSN
VP, Chief Accounting Officer
4,855
0.0043%
$2.00$9,710+2.94%
2024-01-16SaleMersana Therapeutics, Inc.
MRSN
VP, Chief Accounting Officer
5,025
0.0042%
$2.71$13,618-6.27%
2023-01-17SaleMersana Therapeutics, Inc.
MRSN
VP, Controller
3,575
0.0033%
$5.74$20,521-41.65%
2022-01-18SaleMersana Therapeutics, Inc.
MRSN
VP, Controller
3,964
0.0052%
$5.92$23,467-7.05%
2021-07-01SaleMersana Therapeutics, Inc.
MRSN
VP, Controller
1,884
0.0026%
$13.60$25,622-56.37%
2021-01-19SaleMersana Therapeutics, Inc.
MRSN
VP, Controller
1,090
0.0008%
$10.64$11,598-40.52%
2021-01-04SaleMersana Therapeutics, Inc.
MRSN
VP, Controller
494
0.0004%
$13.38$6,610-48.11%
2020-07-02SaleMersana Therapeutics, Inc.
MRSN
VP, Controller
6,766
0.0101%
$22.49$152,167-15.72%
2020-06-30PurchaseMersana Therapeutics, Inc.
MRSN
VP, Controller
6,766
0.0058%
$13.68$92,559-20.36%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.